Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know, neither could I.
So we made it to another weekend and in the 2 1/2 years I've owned TITAN, there have been no weekend developments causing disruptions to my investment. I feel that I can breathe a sigh of relief!
Until Monday........
Great post 66Mustang, very encouraging but a word about that "Mustang". My future father-in-law let me use his brand new 1965 Mustang Convertible with a 289 cu.in.V8 in powder blue every weekend while I dated his daughter. I was 17 and she was 16, and OMG what a ride!!! The car was spectacular too. I remember one night going to a Drive-In on Rte 22 in Union, NJ to see Night of the Living Dead. Gotta admit it scared the crap out of me, especially in a soft top car. Thanks for the post 66M and especially for the memory. GO TITAN and GLTA
Keny...me boy...you're out on a limb here, and you're dead wrong. Where do you guys get these ideas?
With all due respect, you have totally misinterpreted these statements by Amarin. They will seek approval if trial is stopped for overwhelming efficacy, otherwise the trial will continue until targeted event reached. That's all she wrote! Sorry century man.
Mr. Gabor, thank you sincerely for taking the time to illuminate many of the business considerations relevant to this company and therefore critical to the posters on this board. We are all indebted to you and I for one am grateful for your presence here....with or without the accent!
HDG, you are rarely incorrect in your assertions, but I gotta go with BB on this one. FDA was obligated to give Amarin an opportunity to schedule a meeting before rescission and they failed to do so. FDA definitely f'ked Amarin over, there's no denying it!
But unfortunately for all of us, you are NOT wrong. And the shlubs like me sitting on a massive position and afraid to sell (less we miss the major rally), well we just watch and wait. Though as time passes, it does get more and more difficult.
I wouldn't place any bets on that, may be there next week......
They are going to kill it if it doesn't breakout real soon..........
Sorry JMAC but I have to totally agree with Diamond's conclusion on the pricing of a BO even at today's depressed price. Don't see how you could possibly arrive at sub $1.00 offer!! I will, however, refrain from busting you about the news you alluded to that hasn't materialized....completely out of your control.
Will today be the day they tank it....cause it's having trouble pushing through the upper boundary? I will never feel confident about positive PPS activity in this stock.....until I've sold my last share!!
I f'ing hope you do, BB, I hope you succeed.
I'm afraid that many of us have limited ability to take on the roll of crusaders, but is there someone on the board who could readily provide the names of Titan board members and their contact information. Maybe we should be directing our concerns to them instead of to the executive management. After all, the execs are getting the biggest benefit, with salaries and bonus shares, and they may be perfectly happy with the "status quo"!
Any chance JH might be mistakenly used in the cadaver testing? Just kidding....really, I am.
Longmoney, many thanks for the informative posts! Just wondering if the subject of why the Sport was not present at the conference was discussed at all?
Don't believe this will be about Hargrove, most likely the Longtai deal is closing. Not earth shattering but still important, just hope the robot missing from AORN Conference doesn't overshadow.
Sometimes I feel incredibly distraught by the moronic posts that appear on this board. Thankfully that feeling is lifted by the considerably higher number of truly useful and informative posts that follow!
Well I guess it will be you (again!) who looks like the fool, urchin. You completely misrepresented Fishy's position. I'll leave it in his hands to publish the correction. You really ought to take it down a few notches.
The air required to phrase your comments is far more valuable than any of their actual content. Please stop wasting air.
Just Google it.
CJR, another "Golden Nugget", dare I say "Diamond" of a post! It only remains to be seen if it educates and quiets some of the loudest mouths on this board. One can hope!
I couldn't figure it out, FUD...Duh! Thanks again North.
THANK YOU Merc! Factual, intelligent and entertaining. We need more of this.
It's good to see we're almost keeping pace with generic Lovaza. Go AMRN!
You know I think you've hit the nail on the head, BB! God Bless the FDA and America, too!
Would someone post what the letters "FUD" represent please? Thanks in advance.
I'm sorry BB, suffering from brain fart.......what is the significance of V remaining on the Paragraph 4 Patent list?
Yes thank you, and good luck getting your head out of your butt!
Quick dip. Hmm, is there some bad news somewhere or just the MMs screwing around? Have they stopped trading?
I wonder if we can get into the red by the end of the trading day? I bet we can and I have to finally sell this turd. Can't handle this any longer, au revoir!
You're correct DML, that phrase might refer to something more than was previously granted. Perhaps it would allow "off-label" communications about the benefit of Vascepa for treatment of DES or in Dialysis patients. I guess we'll see! GLTA
Yes, that's what we continue to hope! I guess we'll see.
Zum, I do read every one of your science based posts and am forever grateful to you for the effort you expend, and
JL, I am in complete agreement with you and Zum on the MOA of EPA in reducing inflammation.
My comment was not intended in any way to assail your collective views on the action of EPA or to repudiate any of its benefits. In fact, I am in full agreement with you both!
Alarms were raised for me as I read the study posted by "Dancing" especially the bottom line identified by Dr. Weyand.
"In the lab, the scientists tested a drug designed to prevent PKM2's status change and succeeded in lowering the IL-6 output of patient-derived M1 macrophages".
"The good news, Weyand said, is that several interventions -- blocking glucose uptake, sponging up free radicals and preventing PKM2's status change -- reduce the macrophages' excess inflammatory activity. This could lead to new therapeutic approaches, she said".
As ignorant as they may be about eicosanoid effects, they have nonetheless succeeded in clarifying several important metabolic functions that raise CVD risk through inflammatory activity AND they have identified workable treatment alternatives to reduce that inflammation. Unfortunately for us, these are in addition to Vascepa.
To me that spells c-o-m-p-e-t-i-t-i-o-n, thus the alarm bells. They are on the right track, the same track as Vascepa!
And where are we? Well, we're trying to sell our extraordinary product as best we can while the "Barbarians" are at our gate. Basically, we wait.....for sales, for NCE (lol), for 1A, for R-It.
Dr.Weyand doesn't mention the drugs used by her team so there is no way to know their status or how long it might take to get to market. The FDA will certainly do their part to help Stanford Medical move forward while doing everything possible to hold Amarin close to the starting gate.
"The team's work is an example of Stanford Medicine's focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill".
I wonder if Stanford will make a better impression than Amarin? I guess we'll see! JMO
Not exactly a banner result for Vascepa disciples. A discovery that could compete with V if they can harness the drug that prevents the change to PKM2 status and succeed in lowering IL-6 output of the patient's M1 macrophages. The drop in inflammation seems to be very significant. JMO but I guess we'll see!
Give it a rest marz, Coleman was an arrogant prick. His attitude toward "fish oil" (and therefore Vascepa) was probably partially responsible for his death. He should have been on full dose V. Too bad he died but other than his family, who cares.....everybody has to go sometime friend.
Thanks again HDG!
Thanks, as always, HDG.
Just one quick clarification, should the highlighted date below read 1/1/2015?
"The 7,350 patients (enrolled till 12/31/2014) generated 47 events, meanwhile the 550 patients (enrolled after 12/31/2014) generated 3 events between 1/1/2016 - 2/24/2016"
Appreciate all your commentary......GLTA
Raf, exactly what does the placebo rate represent in your tabulation?
If this "investment conference" doesn't nudge the PPS up a little, then there's no hope left. Might as well bend over and kiss it goodbye!! LOL
There is no logical reason for another delay. Anyone who persists in conjuring a justification for one is delusional. If there is another delay (likely), it is because the FDA has hoodwinked Amarin management once again. The singular agenda here is the FDA continuing its position of delaying all actions on our issues until "hell freezes over" (if possible)! JMO-GLTA